These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22738083)

  • 1. Quantum pharmacology for infectious diseases: a molecular connectivity approach.
    Singh S
    Curr Comput Aided Drug Des; 2012 Sep; 8(3):249-54. PubMed ID: 22738083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quantum pharmacology: state of scientific research].
    Chekman IS
    Lik Sprava; 2007; (8):3-11. PubMed ID: 18714459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QM/MM approaches in medicinal chemistry research.
    Menikarachchi LC; Gascón JA
    Curr Top Med Chem; 2010; 10(1):46-54. PubMed ID: 19929827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantum mechanical methods for drug design.
    Zhou T; Huang D; Caflisch A
    Curr Top Med Chem; 2010; 10(1):33-45. PubMed ID: 19929831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid Quantum Mechanics/Molecular Mechanics (QM/MM) Simulation: A Tool for Structure-Based Drug Design and Discovery.
    Kulkarni PU; Shah H; Vyas VK
    Mini Rev Med Chem; 2022; 22(8):1096-1107. PubMed ID: 34620049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. User-Friendly Quantum Mechanics: Applications for Drug Discovery.
    Kotev M; Sarrat L; Gonzalez CD
    Methods Mol Biol; 2020; 2114():231-255. PubMed ID: 32016897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-principles modeling of biological systems and structure-based drug-design.
    Sgrignani J; Magistrato A
    Curr Comput Aided Drug Des; 2013 Mar; 9(1):15-34. PubMed ID: 23106775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipophilicity in drug design: an overview of lipophilicity descriptors in 3D-QSAR studies.
    Ginex T; Vazquez J; Gilbert E; Herrero E; Luque FJ
    Future Med Chem; 2019 May; 11(10):1177-1193. PubMed ID: 30799643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to molecular topology: basic concepts and application to drug design.
    Gálvez J; Gálvez-Llompart M; García-Domenech R
    Curr Comput Aided Drug Des; 2012 Sep; 8(3):196-223. PubMed ID: 22734705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSPR models for computer-aided drug design in microbiology, parasitology, and pharmacology.
    Gonzalez-Diaz H
    Curr Comput Aided Drug Des; 2011 Dec; 7(4):228-30. PubMed ID: 22050675
    [No Abstract]   [Full Text] [Related]  

  • 11. What Next for Quantum Mechanics in Structure-Based Drug Discovery?
    Bryce RA
    Methods Mol Biol; 2020; 2114():339-353. PubMed ID: 32016902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of quantum mechanics in structure-based drug design.
    Raha K; Peters MB; Wang B; Yu N; Wollacott AM; Westerhoff LM; Merz KM
    Drug Discov Today; 2007 Sep; 12(17-18):725-31. PubMed ID: 17826685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR and QM/MM approaches applied to drug metabolism prediction.
    Braga RC; Andrade CH
    Mini Rev Med Chem; 2012 Jun; 12(6):573-82. PubMed ID: 22587770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation with quantum mechanics/molecular mechanics for drug discovery.
    Barbault F; Maurel F
    Expert Opin Drug Discov; 2015 Oct; 10(10):1047-57. PubMed ID: 26289577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-aided Drug Design and Drug Pharmacokinetic Prediction: A Mini-review.
    Tabeshpour J; Sahebkar A; Zirak MR; Zeinali M; Hashemzaei M; Rakhshani S; Rakhshani S
    Curr Pharm Des; 2018; 24(26):3014-3019. PubMed ID: 30179125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and SAR Analysis of Covalent Inhibitors Driven by Hybrid QM/MM Simulations.
    Lodola A; Callegari D; Scalvini L; Rivara S; Mor M
    Methods Mol Biol; 2020; 2114():307-337. PubMed ID: 32016901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QM Implementation in Drug Design: Does It Really Help?
    Liu J; He X
    Methods Mol Biol; 2020; 2114():19-35. PubMed ID: 32016884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational quantum chemistry and adaptive ligand modeling in mechanistic QSAR.
    De Benedetti PG; Fanelli F
    Drug Discov Today; 2010 Oct; 15(19-20):859-66. PubMed ID: 20709183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the contribution of molecular topology to drug design and discovery.
    Gálvez J; García-Doménech R
    Curr Comput Aided Drug Des; 2010 Dec; 6(4):252-68. PubMed ID: 20883200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.